Revision history

mTOR Inhibition and Rapamycin

A representative changelog for this entry. Timestamps and editors are illustrative of the review cadence used across the atlas.

Jun 20, 2026

Reviewed evidence standing (early human) and refreshed the watchlistcurrent

@ext.contrib · 5,200 bytes

May 24, 2026

Added 2 reference(s) and tightened the mechanism note

@atlas-review · 4,771 bytes

Apr 27, 2026

Expanded the "Mechanism" section

@gero.desk · 4,342 bytes

Mar 31, 2026

Set risk to Moderate and reversibility to Reversible

@biotech.watch · 3,913 bytes

Mar 4, 2026

Created the page from the portal outline

@clinical.eval · 3,484 bytes